Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plaque Psoriasis: Usability of the Risankizumab Autoinjector Combination Product in Adults With Moderate to Severe Psoriasis

NCT03875508 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03875508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03875508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plaque Psoriasis: Usability of the Risankizumab Autoinjector Combination Product in Adults With Moderate to Severe Psoriasis
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
June 4, 2019
Completion date
August 25, 2020
Enrollment
108 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis